Clawback: The Innovative Pharma Market is Collapsing
Fewer than 2 out of 10 treatments are covered by the state, severely limiting patients’ access to innovative and critical therapies. Following the meeting between the Minister of Health, Mr. Adonis Georgiadis, and the pharmaceutical industry associations, the issue of mandatory clawback payments for the first half of 2023 is being hastily addressed, with the…